Clinical Trial Update: Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

View source ↗

Summary

Clinical trial protocol comparing subcutaneous and intravenous vedolizumab for inflammatory bowel disease, incorporating a remote monitoring intervention to ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Mercy Medical Center | Conditions: Inflammatory Bowel Disease (IBD), Crohn's Disease | Status: RECRUITING